Suppr超能文献

乳腺癌免疫治疗疫苗研发的当前方法

Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer.

作者信息

Allahverdiyev Adil, Tari Gamze, Bagirova Melahat, Abamor Emrah Sefik

机构信息

Department of Bioengineering, Faculty of Chemical and Metallurgical Engineering, Yildiz Technical University, Istanbul, Turkey.

出版信息

J Breast Cancer. 2018 Dec;21(4):343-353. doi: 10.4048/jbc.2018.21.e47. Epub 2018 Oct 29.

Abstract

Cancer is the leading cause of death worldwide. In developed as well as developing countries, breast cancer is the most common cancer found among women. Currently, treatment of breast cancer consists mainly of surgery, chemotherapy, hormone therapy, and radiotherapy. In recent years, because of increased understanding of the therapeutic potential of immunotherapy in cancer prevention, cancer vaccines have gained importance. Here, we review various immunotherapeutic breast cancer vaccines including peptide-based vaccines, whole tumor cell vaccines, gene-based vaccines, and dendritic cell vaccines. We also discuss novel nanotechnology-based approaches to improving breast cancer vaccine efficiency.

摘要

癌症是全球主要的死亡原因。在发达国家和发展中国家,乳腺癌都是女性中最常见的癌症。目前,乳腺癌的治疗主要包括手术、化疗、激素疗法和放射疗法。近年来,由于对免疫疗法在癌症预防中的治疗潜力有了更多了解,癌症疫苗变得越发重要。在此,我们综述了各种免疫治疗性乳腺癌疫苗,包括基于肽的疫苗、全肿瘤细胞疫苗、基于基因的疫苗和树突状细胞疫苗。我们还讨论了基于纳米技术的新型方法,以提高乳腺癌疫苗的效率。

相似文献

1
Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer.
J Breast Cancer. 2018 Dec;21(4):343-353. doi: 10.4048/jbc.2018.21.e47. Epub 2018 Oct 29.
2
Cancer vaccines as a targeted immunotherapy approach for breast cancer: an update of clinical evidence.
Expert Rev Vaccines. 2022 Mar;21(3):337-353. doi: 10.1080/14760584.2022.2021884. Epub 2022 Jan 6.
3
Therapeutic breast cancer vaccines: a new strategy for early-stage disease.
BioDrugs. 2009;23(5):277-87. doi: 10.2165/11313490-000000000-00000.
4
New Immunotherapy Strategies in Breast Cancer.
Int J Environ Res Public Health. 2017 Jan 12;14(1):68. doi: 10.3390/ijerph14010068.
5
Immunotherapy for the treatment of breast cancer.
Expert Opin Biol Ther. 2017 Jul;17(7):797-812. doi: 10.1080/14712598.2017.1324566. Epub 2017 May 8.
6
Progress in Vaccine Therapies for Breast Cancer.
Adv Exp Med Biol. 2017;1026:315-330. doi: 10.1007/978-981-10-6020-5_15.
7
Immunotherapeutic approaches for the treatment of breast cancer.
J Mammary Gland Biol Neoplasia. 1999 Oct;4(4):353-65. doi: 10.1023/a:1018714300217.
9
Immunotherapy in breast cancer: Current status and future directions.
Adv Cancer Res. 2019;143:295-349. doi: 10.1016/bs.acr.2019.03.006. Epub 2019 May 2.
10
MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.
Expert Opin Biol Ther. 2010 Jul;10(7):1037-48. doi: 10.1517/14712598.2010.485185.

引用本文的文献

1
An Investigation of the Met1915Thr Polymorphism in Azerbaijani Breast Cancer Patients.
Med Sci (Basel). 2025 Jul 31;13(3):103. doi: 10.3390/medsci13030103.
2
Oxidized Mannan: A Novel Adjuvant Candidate for Enhancing Immune Responses in Veterinary Rabies Vaccine.
Chonnam Med J. 2025 May;61(2):84-89. doi: 10.4068/cmj.2025.61.2.84. Epub 2025 May 23.
3
Personalized neoantigen cancer vaccines: current progression, challenges and a bright future.
Clin Exp Med. 2024 Sep 26;24(1):229. doi: 10.1007/s10238-024-01436-7.
5
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy.
Biomedicines. 2023 Jan 20;11(2):294. doi: 10.3390/biomedicines11020294.
6
Gut Microbiota and Immunotherapy.
Front Microbiol. 2022 Jul 1;13:945887. doi: 10.3389/fmicb.2022.945887. eCollection 2022.
7
Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination.
Front Immunol. 2021 Nov 24;12:786286. doi: 10.3389/fimmu.2021.786286. eCollection 2021.
8
Advancements in Human Breast Cancer Targeted Therapy and Immunotherapy.
J Cancer. 2021 Oct 11;12(23):6949-6963. doi: 10.7150/jca.64205. eCollection 2021.
10
From Conventional to Precision Therapy in Canine Mammary Cancer: A Comprehensive Review.
Front Vet Sci. 2021 Feb 17;8:623800. doi: 10.3389/fvets.2021.623800. eCollection 2021.

本文引用的文献

2
Virus-like particle display of HER2 induces potent anti-cancer responses.
Oncoimmunology. 2018 Jan 5;7(3):e1408749. doi: 10.1080/2162402X.2017.1408749. eCollection 2018.
5
Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.
Oncotarget. 2017 Oct 23;8(58):99161-99178. doi: 10.18632/oncotarget.21959. eCollection 2017 Nov 17.
7
Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
PLoS One. 2017 Oct 18;12(10):e0185099. doi: 10.1371/journal.pone.0185099. eCollection 2017.
8
A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice.
J Drug Target. 2018 Apr;26(4):365-372. doi: 10.1080/1061186X.2017.1387788. Epub 2017 Oct 18.
9
Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.
Bioconjug Chem. 2017 Nov 15;28(11):2756-2771. doi: 10.1021/acs.bioconjchem.7b00502. Epub 2017 Oct 13.
10
GK-1 peptide reduces tumor growth, decreases metastatic burden, and increases survival in a murine breast cancer model.
Vaccine. 2017 Oct 9;35(42):5653-5661. doi: 10.1016/j.vaccine.2017.08.060. Epub 2017 Sep 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验